Testing effectiveness (Phase 2)Study completedNCT03802396
What this trial is testing
Modulating ApoE Signalling to Reduce Brain Inflammation, deLirium and postopErative Cognitive Dysfunction
Who this might be right for
Postoperative DeliriumPostoperative Cognitive Dysfunction
Miles Berger, MD PhD 203